Close Menu

NEW YORK – GenMark Diagnostics reported after the close of the market on Wednesday that its third quarter revenues increased 104 percent year over year, driven in part by ePlex Respiratory Pathogen Panel 2 (RP2) sales.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.